VDR基因变异FokI和ApaI:与易患多发性硬化症相关的因素
Laith Al-Eitan1,2, Salma Darabseh1
1Department of Applied Biological Sciences, Jordan University of Science and Technology, Irbid, Jordan.
PloS one
|September 17, 2025
概括
维生素D受体 (VDR) 基因的遗传变异,特别是FokI和ApaI,与约旦人的多发性硬化症 (MS) 风险增加有关. 在MS患者中,FokI还与维生素D缺乏相关.
科学领域:
- 神经免疫学 神经免疫学
- 人类遗传学 人类遗传学
- 内分泌学 在内分泌学.
背景情况:
- 多发性硬化症 (MS) 是一种自身免疫性中枢神经系统疾病.
- 维生素D由维生素D受体 (VDR) 介导,在生物调节中起作用.
- 约旦MS患者的VDR基因多态仍然没有被检查.
研究的目的:
- 在约旦调查VDR基因多态 (TaqI,BsmI,ApaI,FokI) 与MS易感性之间的关联.
- 探索维生素D状况,VDR多态性和约旦人的MS发作之间的关系.
主要方法:
- 使用Sequenom MassARRAY进行VDR基因SNP (TaqI,BsmI,ApaI,FokI) 的基因定型.
- 研究队列:218名多发性硬化患者和约旦200名健康对照.
- 对遗传关联的分析和与维生素D状况的相关性.
主要成果:
- 在增加的MS风险和FokI (P=0.03) 和ApaI (P=0.04) VDR多态化之间发现了显著的关联.
- 对于BsmI和TaqI多态,没有发现显著的关联.
- 福基多态性与MS患者的维生素D缺乏有显著的联系 (P=0.03).
结论:
- 在约旦人群中,VDR基因,特别是FokI和Apal多态,可能在MS易感性中发挥作用.
- 在约旦MS患者中,FokI多态性与维生素D缺乏有关.
- 需要对阿拉伯人群中的基因环境相互作用进行进一步的研究,以验证这些遗传联系.
更多相关视频
相关概念视频
Single Nucleotide Polymorphisms-SNPs
17.9K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
17.9K
Genome-wide Association Studies-GWAS
15.3K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
15.3K
Comparing Copy Number Variations and SNPs
18.6K
Sequencing of the human genome has opened up several best-kept secrets of the genome. Scientists have identified thousands of genome variations that exist within a population. These variations can be a single nucleotide or a larger chromosomal variation.
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
18.6K
Factors Affecting Illness
5.1K
When a person's physical, emotional, intellectual, social development or spiritual functioning is compromised, this deviation from a healthy normal state is called illness. Illness creates stress that in turn harms individuals. Irritation, anger, denial, hopelessness, and fear are behavioral and emotional changes an individual experiences in the phases of illness. A variety of factors influence a person's health and well-being.
For instance, risk factors are connected to illness,...
For instance, risk factors are connected to illness,...
5.1K
Factors Affecting Drug Response: Overview
3.0K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
3.0K
Factors Affecting Protein-Drug Binding: Patient-Related Factors
305
Protein-drug binding, a pivotal aspect of pharmacokinetics, is subject to considerable variability influenced by an array of patient-related factors. The intricate interplay of age, individual differences, and pathological conditions significantly impact the binding dynamics and subsequent pharmacological effects.
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
305


